<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722550</url>
  </required_header>
  <id_info>
    <org_study_id>1624INF</org_study_id>
    <nct_id>NCT03722550</nct_id>
  </id_info>
  <brief_title>Second Generation Human Milk Oligosaccharides Blend Study</brief_title>
  <official_title>Growth, Safety and Efficacy of a Starter Infant Formula, Follow-up Formula, and Growing-up Milk Supplemented With a Blend of Five Human Milk Oligosaccharides: a Double-blind, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to show that infants fed these new formulas, containing a blend of 5
      Human Milk Oligosaccharides (HMOs), allow for growth in line with infants fed formulas
      without HMOs.

      There will be different groups in the trial: three formula-fed groups and a breastfed group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      These 5 HMOs are identical to the ones found naturally in human milk. They are natural
      prebiotics (or complex sugars) with potential health benefits. Prebiotics are natural
      compounds that help the establishment of beneficial gut bacteria (such as bifidobacteria),
      while preventing bad bacteria from doing harm. Supplementing diets with certain prebiotics
      has been shown to be well tolerated in adults and infants and to provide potential
      benefits.Therefore, the trial also aims to understand if consuming HMOs supplemented formulas
      could strengthen immunity and prevent common illnesses (for example, respiratory illnesses)
      in infants and toddlers. Furthermore, stool frequency and consistency will be monitored, so
      as to evaluate digestive tolerance to the formula.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2018</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Unique coding of the study products</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the growth of infants between the groups</measure>
    <time_frame>From Study Day 1 to 4 months of age</time_frame>
    <description>To compare the growth (weight gain, g/day) of infants randomized to Test Groups (TG1 or TG2) versus Control Group (CG)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To compare recurrent incidences of illness of infants between the groups</measure>
    <time_frame>From Study Day 1 to 15 months of age</time_frame>
    <description>To compare recurrent incidences of illness (specifically lower respiratory tract illnesses including bronchitis/bronchiolitis), of infants randomized to Test Groups (TG1 or TG2) versus Control Group (CG)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant illness and infection outcomes</measure>
    <time_frame>at different stages of feeding 1st age Infant Formula, 2nd age Follow-up Formula, and 3rd age Growing-up Milk when applicable</time_frame>
    <description>Specific parent-reported infant illness symptoms and physician confirmed diagnoses of lower respiratory tract infection (LRTI), upper respiratory tract infection (URTI), total respiratory tract infection (TRTI), gastrointestinal infection (GII), ear illness [including: otitis media (OM), ear infection, ear inflammation, and ear pain], and fever will be combined to report infant illness and infection outcomes (Episode, incidence, duration, severity, and recurrence)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication use (specifically antimicrobials and antipyretics)</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Medication type and duration of intake will be combined to report the medication use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absenteeism: Time away from daycare (infant) or work (parent)</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Time away from daycare (infant) or work (parent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiome composition, diversity, community type</measure>
    <time_frame>Stool sample collected at infant age less than 0.75, 3, 6, 12, and 15 months of age (a subset of 105 infants per formula group; 90 breastfed infants)</time_frame>
    <description>Fecal microbiota composition, diversity, and microbiota community type will be assessed using cutting-edge next generation sequencing technology and combined to report the Fecal microbiome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal metabolic profile</measure>
    <time_frame>Stool sample collected at infant age less than 0.75, 3, 6, 12, and 15 months of age (a subset of 105 infants per formula group; 90 breastfed infants)</time_frame>
    <description>Measures of fecal metabolism will be combined to report fecal metabolic profile (fecal pH, fecal organic acids, as well as additional targeted/untargeted metabolomics and cell-based functional assays)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of immune and gut health</measure>
    <time_frame>Stool sample collected at infant age less than 0.75, 3, 6, 12, and 15 months of age (a subset of 105 infants per formula group; 90 breastfed infants)</time_frame>
    <description>Fecal markers of immune and gut health will include secretory immunoglobulin A IgA [total], alpha-1 antitrypsin, and calprotectin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Markers of immune health</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>Plasma and peripheral blood mononuclear cells, Extracellular in vivo and ex vivo circulating cytokine levels will be measured in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal tolerance</measure>
    <time_frame>Stool sample collected at infant age less than 0.75, 3, 6, 12, and 15 months of age (a subset of 105 infants per formula group; 90 breastfed infants)</time_frame>
    <description>Stool patterns (stool frequency and consistency), Gastrointestinal symptoms, Gastrointestinal-related behaviors, and milk intake will be combined to report the gastrointestinal tolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive and behavioral outcomes</measure>
    <time_frame>At 15 months of age</time_frame>
    <description>Assessment at 15 months through the use of the MacArthur-Bates Communicative Development Inventories (MCDI) and the Early Childhood Behavior Questionnaire (ECBQ), two parent-reported questionnaires that evaluate early language/vocabulary and development of communication skills, that will be combined to report the cognitive and behavioral outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DNA Genotyping of fucosyltransferase 2 and 3 (secretor status)</measure>
    <time_frame>At Study Day 60 +/- 5 days</time_frame>
    <description>Association between secretor status and illnesses/infections via microbiome modulation will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breastmilk collection for Human Milk Oligosaccharides profile analysis (breastfeeding mothers only)</measure>
    <time_frame>At Study Day 90 +/- 5 days</time_frame>
    <description>A small sample of milk (1ml) will be hand pumped, collected in an Eppendorf tube and stored frozen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements: Weight</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Weight measurements in grams to report anthropometric measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements: Length</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Length measurements in centimeters to report anthropometric measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements: Head circumference</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Head circumference measurements in centimeters to report anthropometric measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements: BMI</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>BMI measurements in kg/m^2 to report anthropometric measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements: World Health Organization (WHO) growth standard calculated z-scores</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>WHO growth standard z-scores including weight-for-age, length-for-age, weight-for-length, head-circumference-for-age, BMI-for-age and weight velocity will be calculated and combined to report anthropometric measurements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs: Infant respiration</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Infant respiration in breaths per minute will also be measured to report vital signs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs: Heart rate</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Heart rate in beasts per minute will also be measured to report vital signs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs: Body temperature</measure>
    <time_frame>From enrollment until 15 months of age</time_frame>
    <description>Body temperature in Celsius degree will also be measured to report vital signs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standard adverse events (AEs) reporting for safety assessment</measure>
    <time_frame>From the time the informed consent form has been signed at enrollment infant age less than 21 days or 0.75 months through the 2 weeks post-study telephone contact at infant age 464 days</time_frame>
    <description>Reported adverse events (AEs) and Serious Adverse Events (SAEs) include type, incidence, severity, seriousness and relation to feeding</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">570</enrollment>
  <condition>Healthy Infants</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Starter Infant Formula, Standard Follow-up Formula, and Standard Growing-up Milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starter Infant Formula (same as Control Group) supplemented with 1.5g/L of Human Milk Oligosaccharides, Follow-up Formula (same as Control Group) supplemented with 0.5g/L of Human Milk Oligosaccharides, and Growing-up Milk (same as Control Group) supplemented with 0.4g/L of Human Milk Oligosaccharides</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Starter Infant Formula (same as Control Group) supplemented with 2.5g/L of Human Milk Oligosaccharides, Follow-up Formula (same as Control Group) supplemented with 0.5g/L of Human Milk Oligosaccharides, and Growing-up Milk (same as Control Group) supplemented with 0.4g/L of Human Milk Oligosaccharides</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breastfed Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-randomized Breastfed reference group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Starter Infant Formula, Follow-up Formula, and Growing-up Milk Supplemented With a Blend of Five Human Milk Oligosaccharides</intervention_name>
    <description>Study formulas are administered orally, ad libitum, from enrollment until 15 months of age</description>
    <arm_group_label>Test Group 1</arm_group_label>
    <arm_group_label>Test Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Breast-feeding</intervention_name>
    <description>Exclusive Breast-feeding up to 4 months of age</description>
    <arm_group_label>Breastfed Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Starter Infant Formula, Follow-up Formula, and Growing-up Milk</intervention_name>
    <description>Standard Study formulas are administered orally, ad libitum, from enrollment until 15 months of age</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Evidence of personally signed and dated informed consent document indicating that the
             infant's parent(s)/Legally Acceptable Representative has been informed of all
             pertinent aspects of the study.

          2. Infants whose parent(s)/Legally Acceptable Representative have reached the legal age
             of majority in the countries where the study is conducted.

          3. Infants whose parent(s)/Legally Acceptable Representative are willing and able to
             comply with scheduled visits, and the requirements of the study protocol.

          4. Infants whose parent(s)/Legally Acceptable Representative are able to be contacted
             directly by telephone throughout the study.

          5. Infants whose parent(s)/Legally Acceptable Representative have a working freezer.

          6. Infants must meet all of the following inclusion criteria to be eligible for
             enrollment into the study:

               1. Healthy term (37-42 weeks of gestation) infant at birth.

               2. At enrollment visit, post-natal age ≥ 7 days and ≤ 21 days (date of birth = day
                  0, 0.25 - 0.75 months old).

               3. At enrollment, birth weight ≥ 2500g and ≤ 4500g.

               4. For formula-fed group, infants must be exclusively consuming and tolerating a
                  cow's milk infant formula at time of enrollment and their parent(s)/Legally
                  Acceptable Representative must have independently elected, before enrollment, not
                  to breastfeed.

               5. For breastfed group, infants must have been exclusively consuming breast milk
                  since birth, and their parent(s)/Legally Acceptable Representative must have made
                  the decision to continue exclusively breastfeeding until at least 4 month of age.

        Exclusion Criteria:

          1. Infants with conditions requiring infant feedings other than those specified in the
             protocol.

          2. Infants receiving complementary foods or liquids defined as 4 or more teaspoons per
             day or approximately 20 g per day of complementary foods or liquids at or prior to
             enrollment.

          3. Infants who have a medical condition or history that could increase the risk
             associated with study participation or interfere with the interpretation of study
             results, including:

               1. Evidence of major congenital malformations (e.g., cleft palate, extremity
                  malformation).

               2. Suspected or documented systemic or congenital infections (e.g., human
                  immunodeficiency virus, cytomegalovirus, syphilis).

               3. History of admission to the Neonatal Intensive Care Unit (NICU), with the
                  exception of admission for jaundice phototherapy.

               4. Other severe medical or laboratory abnormality (acute or chronic) which, in the
                  judgment of the investigator, would make the infant inappropriate for entry into
                  the study.

          4. Infants who are presently receiving or have received prior to enrollment any of the
             following: medication(s) or supplement(s) which are known or suspected to affect the
             following: fat digestion, absorption, and/or metabolism (e.g., pancreatic enzymes);
             stool characteristics (e.g., glycerin suppositories, bismuth-containing medications,
             docusate, Maltsupex, or lactulose); growth (e.g. insulin or growth hormone); gastric
             acid secretion; or any study outcomes.

          5. Currently participating or having participated in another clinical trial since birth
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aleksander Krasnow, Lek. Med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gdańskie Centrum Zdrowia Sp. Z o.o.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wiesław Olechowski, Dr n.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>ALERGO-MED Specjalistyczna Przychodnia Lekarska Sp. Z o.o.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sylwia Korzyńska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Medyczne Pratia Ostrolęka</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Płoszczuk, Dr. n.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny Anna Płoszczuk</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magdalena Sidorowicz, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Medyczne Pratia Warszawa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grażyna Jasieniak-Pinis, Lek. Med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>ATOPIA Niepubliczny Zakład Opieki Zdrowotnej Poradnie Specjalistyczne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bartosz Korczowski, PhD MD Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korczowski Bartosz Gabinet Lekarski</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Piotr Korbal, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Szpital Uniwersytecki nr 2 Im. Dr Jana Biziela w Bydgoszczy Oddział Kliniczny Noworodków, Wcześniaków z Intensywną Terapią Noworodka wraz z</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marta Żołnowska, Lek. Med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Medyczne Plejady</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bogusław Cimoszko, Lek. Med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Vitae Sp z o.o. Poradnia Podstawowej Opieki Zdrowotnej</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wanda Furmaga-Jabłonska, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uniwersytecki Szpital Dziecięcy w Lublinie</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marzena Nowak, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Medyczne PROMED</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georgios Marek Vasilopoulos, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum Innowacyjnych Terapii Sp. z o.o.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Viktor Bauer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Kenessey Albert Kórház-Rendelőintézet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Simkó, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Futurenest Kft.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>István Laki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kanizsai Dorottya Kórház</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Éva Kovács, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Házi Gyermekorvosi Rendelő / Babadoki Kft.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Éva Szabó, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Csolnoky Ferenc Kórház</affiliation>
  </overall_official>
  <overall_official>
    <last_name>István Tokodi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mentaház Magánorvosi Központ Kft.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zsuzsanna Tengelyi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinexpert Kft.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Katalin Fister, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinexpert Gyöngyös Egészségügyi Szolgáltató Kft.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anton Bilev, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MC ''Sveti Ivan Rilski - Chudotvorets''</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miroslava Bosheva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Multiorofile Hospital for active treatment Sveti Georgi EAD, Pediatric clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Toni Grigorov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multiprofile Hospital for Active Treatment City Clinic - Sveti Georgi EOOD,Department of Paediatrics,</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rositsa Karcheva-Beloeva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Center-1-Sevlievo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Margarita Koleva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diagnostic-consultative center Ritam TR</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stelyana Kraeva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alitera -Med-Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olga Nikolova, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multiprofile Hospital for Active Treatment Sveti Ivan Rilski Kozloduy,Department of Pediatrics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tatyana Stoeva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Centre - Izgrev</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Tarneva, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital 'Deva Maria', Department for Naonatology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Svilen Dosev, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multiprofile Hospital for Active treatment Ruse AD, Department of Paediatrics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan Banov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SMA Dr Stefan Banov</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sirma Dimitrova, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Center Excelsior</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Malgorzata Arciszewska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poliklinika Ginekolo.-Poloznicza</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sebastien Paoli, MSc</last_name>
    <phone>+41797111417</phone>
    <email>sebastien.paoli@rdls.nestle.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cecile Nicolas-Denizou</last_name>
    <phone>+41217858606</phone>
    <email>Cecile.NicolasDenizou@rd.nestle.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sveti Ivan Rilski - Chudotvorets</name>
      <address>
        <city>Blagoevgrad</city>
        <zip>2700</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Deva Maria, Department for Naonatology</name>
      <address>
        <city>Burgas</city>
        <zip>8000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment Sveti Ivan Rilski Kozloduy,Department of Pediatrics</name>
      <address>
        <city>Kozloduy</city>
        <zip>3320</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment City Clinic - Sveti Georgi EOOD,Department of Paediatrics</name>
      <address>
        <city>Montana</city>
        <zip>3400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Multiorofile Hospital for active treatment Sveti Georgi EAD, Pediatric clinic</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active treatment- Ruse AD, Department of Paediatrics</name>
      <address>
        <city>Ruse</city>
        <zip>7000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center-1-Sevlievo EOOD</name>
      <address>
        <city>Sevlievo</city>
        <zip>5400</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>1st Pediatric Consultative Clinic</name>
      <address>
        <city>Sofia</city>
        <zip>1404</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Excelsior</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Centre - Izgrev EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1612</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Alitera-Med-Medical Center EOOD</name>
      <address>
        <city>Sofia</city>
        <zip>1618</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diagnostic-consultative center Ritam TR'' OOD</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SMA Dr Stefan Banov</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Kenessey Albert Kórház-Rendelőintézet Csecsemő és Gyermekosztály</name>
      <address>
        <city>Balassagyarmat</city>
        <zip>2660</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinexpert Kft.</name>
      <address>
        <city>Budapest</city>
        <zip>1033</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinexpert Gyöngyös Egészségügyi Szolgáltató Kft.</name>
      <address>
        <city>Gyöngyös</city>
        <zip>3200</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Futurenest Kft.</name>
      <address>
        <city>Miskolc</city>
        <zip>3527</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kanizsai Dorottya Kórház Csecsemő és Gyermekgyógyászati Osztály</name>
      <address>
        <city>Nagykanizsa</city>
        <zip>8800</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Házi Gyermekorvosi Rendelő / Babadoki Kft.</name>
      <address>
        <city>Szeged</city>
        <zip>6723</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mentaház Magánorvosi Központ Kft.</name>
      <address>
        <city>Székesfehérvár</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Csolnoky Ferenc Kórház</name>
      <address>
        <city>Veszprém</city>
        <zip>8200</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny Anna Płoszczuk</name>
      <address>
        <city>Białystok</city>
        <zip>15-430</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Poliklinika Ginekolo.-Poloznicza</name>
      <address>
        <city>Białystok</city>
        <zip>15-435</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Malgorzata Arciszewska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki nr 2</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Vitae Sp z o.o. Poradnia Podstawowej Opieki Zdrowotnej</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-180</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gdańskie Centrum Zdrowia Sp. Z o.o</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-542</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Plejady</name>
      <address>
        <city>Kraków</city>
        <zip>30-363</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Grażyna Jasieniak-Pinis ATOPIA Niepubliczny Zakład Opieki Zdrowotnej Poradnie Specjalistyczne</name>
      <address>
        <city>Kraków</city>
        <zip>31-159</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne PROMED</name>
      <address>
        <city>Kraków</city>
        <zip>31-411</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Dziecięcy w Lublinie</name>
      <address>
        <city>Lublin</city>
        <zip>20-093</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Ostrolęka</name>
      <address>
        <city>Ostrołęka</city>
        <zip>07-410</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Innowacyjnych Terapii Sp. z o.o.</name>
      <address>
        <city>Piaseczno</city>
        <zip>05-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Korczowski Bartosz Gabinet Lekarski</name>
      <address>
        <city>Rzeszów</city>
        <zip>35-302</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ALERGO-MED Specjalistyczna Przychodnia Lekarska Sp. Z o.o</name>
      <address>
        <city>Tarnów</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Warszawa</name>
      <address>
        <city>Warsaw</city>
        <zip>01-868</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Hungary</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 27, 2018</study_first_submitted>
  <study_first_submitted_qc>October 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

